Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Agnes Jager, MD PhD"'
Autor:
Marianne J. Heins, Kelly M. de Ligt, Janneke Verloop, Sabine Siesling, Joke C. Korevaar, Annette Berendsen, PhD, Daan Brandenbarg, PhD, Anneriet Dassen, MD PhD, Agnes Jager, MD PhD, Jacqueline Hugtenburg, PhD, Gerda van der Weele, PhD
Publikováno v:
Breast, Vol 61, Iss , Pp 22-28 (2022)
Background: The number of breast cancer survivors increases, but information about long-term adverse health effects in breast cancer survivors is sparse. We aimed to get an overview of the health effects for which survivors visit their general practi
Externí odkaz:
https://doaj.org/article/723bb6c16208429898c553131ddf66ee
Autor:
Braal CL; C. Louwrens Braal, PharmD, Erasmus University Medical Center, Rotterdam, the Netherlands; Jos H. Beijnen, PhD, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands, and Utrecht University, Utrecht, the Netherlands; Stijn L.W. Koolen, PhD, PharmD and Esther Oomen-de Hoop, PhD, Erasmus University Medical Center, Rotterdam, the Netherlands; Neeltje Steeghs, MD, PhD, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands; Agnes Jager, MD, PhD, Erasmus University Medical Center, Rotterdam, the Netherlands; Alwin D.R. Huitema, PharmD, PhD, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands, and Utrecht University, Utrecht, the Netherlands; and Ron H.J. Mathijssen, MD, PhD, Erasmus University Medical Center, Rotterdam, the Netherlands., Beijnen JH; C. Louwrens Braal, PharmD, Erasmus University Medical Center, Rotterdam, the Netherlands; Jos H. Beijnen, PhD, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands, and Utrecht University, Utrecht, the Netherlands; Stijn L.W. Koolen, PhD, PharmD and Esther Oomen-de Hoop, PhD, Erasmus University Medical Center, Rotterdam, the Netherlands; Neeltje Steeghs, MD, PhD, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands; Agnes Jager, MD, PhD, Erasmus University Medical Center, Rotterdam, the Netherlands; Alwin D.R. Huitema, PharmD, PhD, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands, and Utrecht University, Utrecht, the Netherlands; and Ron H.J. Mathijssen, MD, PhD, Erasmus University Medical Center, Rotterdam, the Netherlands., Koolen SLW; C. Louwrens Braal, PharmD, Erasmus University Medical Center, Rotterdam, the Netherlands; Jos H. Beijnen, PhD, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands, and Utrecht University, Utrecht, the Netherlands; Stijn L.W. Koolen, PhD, PharmD and Esther Oomen-de Hoop, PhD, Erasmus University Medical Center, Rotterdam, the Netherlands; Neeltje Steeghs, MD, PhD, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands; Agnes Jager, MD, PhD, Erasmus University Medical Center, Rotterdam, the Netherlands; Alwin D.R. Huitema, PharmD, PhD, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands, and Utrecht University, Utrecht, the Netherlands; and Ron H.J. Mathijssen, MD, PhD, Erasmus University Medical Center, Rotterdam, the Netherlands., Oomen-de Hoop E; C. Louwrens Braal, PharmD, Erasmus University Medical Center, Rotterdam, the Netherlands; Jos H. Beijnen, PhD, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands, and Utrecht University, Utrecht, the Netherlands; Stijn L.W. Koolen, PhD, PharmD and Esther Oomen-de Hoop, PhD, Erasmus University Medical Center, Rotterdam, the Netherlands; Neeltje Steeghs, MD, PhD, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands; Agnes Jager, MD, PhD, Erasmus University Medical Center, Rotterdam, the Netherlands; Alwin D.R. Huitema, PharmD, PhD, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands, and Utrecht University, Utrecht, the Netherlands; and Ron H.J. Mathijssen, MD, PhD, Erasmus University Medical Center, Rotterdam, the Netherlands., Steeghs N; C. Louwrens Braal, PharmD, Erasmus University Medical Center, Rotterdam, the Netherlands; Jos H. Beijnen, PhD, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands, and Utrecht University, Utrecht, the Netherlands; Stijn L.W. Koolen, PhD, PharmD and Esther Oomen-de Hoop, PhD, Erasmus University Medical Center, Rotterdam, the Netherlands; Neeltje Steeghs, MD, PhD, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands; Agnes Jager, MD, PhD, Erasmus University Medical Center, Rotterdam, the Netherlands; Alwin D.R. Huitema, PharmD, PhD, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands, and Utrecht University, Utrecht, the Netherlands; and Ron H.J. Mathijssen, MD, PhD, Erasmus University Medical Center, Rotterdam, the Netherlands., Jager A; C. Louwrens Braal, PharmD, Erasmus University Medical Center, Rotterdam, the Netherlands; Jos H. Beijnen, PhD, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands, and Utrecht University, Utrecht, the Netherlands; Stijn L.W. Koolen, PhD, PharmD and Esther Oomen-de Hoop, PhD, Erasmus University Medical Center, Rotterdam, the Netherlands; Neeltje Steeghs, MD, PhD, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands; Agnes Jager, MD, PhD, Erasmus University Medical Center, Rotterdam, the Netherlands; Alwin D.R. Huitema, PharmD, PhD, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands, and Utrecht University, Utrecht, the Netherlands; and Ron H.J. Mathijssen, MD, PhD, Erasmus University Medical Center, Rotterdam, the Netherlands., Huitema ADR; C. Louwrens Braal, PharmD, Erasmus University Medical Center, Rotterdam, the Netherlands; Jos H. Beijnen, PhD, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands, and Utrecht University, Utrecht, the Netherlands; Stijn L.W. Koolen, PhD, PharmD and Esther Oomen-de Hoop, PhD, Erasmus University Medical Center, Rotterdam, the Netherlands; Neeltje Steeghs, MD, PhD, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands; Agnes Jager, MD, PhD, Erasmus University Medical Center, Rotterdam, the Netherlands; Alwin D.R. Huitema, PharmD, PhD, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands, and Utrecht University, Utrecht, the Netherlands; and Ron H.J. Mathijssen, MD, PhD, Erasmus University Medical Center, Rotterdam, the Netherlands., Mathijssen RHJ; C. Louwrens Braal, PharmD, Erasmus University Medical Center, Rotterdam, the Netherlands; Jos H. Beijnen, PhD, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands, and Utrecht University, Utrecht, the Netherlands; Stijn L.W. Koolen, PhD, PharmD and Esther Oomen-de Hoop, PhD, Erasmus University Medical Center, Rotterdam, the Netherlands; Neeltje Steeghs, MD, PhD, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands; Agnes Jager, MD, PhD, Erasmus University Medical Center, Rotterdam, the Netherlands; Alwin D.R. Huitema, PharmD, PhD, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands, and Utrecht University, Utrecht, the Netherlands; and Ron H.J. Mathijssen, MD, PhD, Erasmus University Medical Center, Rotterdam, the Netherlands.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2019 Aug 01; Vol. 37 (22), pp. 1980-1981. Date of Electronic Publication: 2019 Jun 18.